A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models

We previously developed a polysaccharide-–RBD-conjugated nanoparticle vaccine which induced protective efficacy against SARS-CoV-2 in a mouse model. Here, we newly developed a vaccine, SCTV01A, by chemically conjugating recombinant SARS-CoV-2 RBD-Fc and PPS14 (<i>Streptococcus pneumoniae</i> serotyp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chunyun Sun, Desheng Kong, Erhong Guo, Jun Zhao, Jilei Jia, Rui Wang, Juan Ma, Meng Chen, Jianbo Lu, Chulin Yu, Kuokuo Li, Liangzhi Xie
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-02-01
coleção:	Vaccines
Assuntos:	COVID-19 SARS-CoV-2 conjugated vaccine immunogenicity toxicity
Acesso em linha:	https://www.mdpi.com/2076-393X/11/3/526
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!